I understand that , but when oversubscribed you have to then look at how you would scale back and be fair in doing so.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025